The retail cost of Linzess (linaclotide) can vary significantly depending on factors such as dosage, quantity, insurance coverage, and pharmacy. Without insurance, the estimated retail price for a 30-day supply of Linzess capsules typically ranges from $250 to $300 [1].
How much does Linzess cost with insurance?
Insurance coverage for Linzess can substantially reduce out-of-pocket expenses. Many insurance plans offer co-pays that are considerably lower than the full retail price. The exact co-pay amount depends on the specific insurance formulary and the patient's benefit plan [1]. For example, some plans may have co-pays as low as $10 or $20 for a 30-day supply. Patients are advised to check with their insurance provider to understand their specific coverage details and potential co-pay obligations.
Are there any patient assistance programs for Linzess?
Yes, patient assistance programs are available to help eligible individuals afford Linzess. The manufacturer, Ironwood Pharmaceuticals and AbbVie, offers a co-pay savings program for commercially insured patients. This program can reduce the out-of-pocket cost for eligible patients, potentially lowering their co-pay to as little as $0 for a 12-month supply [1]. Eligibility requirements typically include having commercial insurance and residing in the United States or Puerto Rico. Details and enrollment information can usually be found on the official Linzess website or through patient assistance program portals.
What is the difference in cost between Linzess dosages?
Linzess is available in several dosages: 72 mcg, 145 mcg, and 290 mcg. While the cost can vary slightly by dosage, the primary driver of the overall price for a 30-day supply is generally the prescription quantity rather than the strength of the individual capsules [1]. However, if a higher dosage requires more capsules to reach a therapeutic level or if different quantities are prescribed, this could influence the total cost.
Can I get a Linzess coupon or discount?
Discount coupons and savings cards for Linzess are often available through the manufacturer's website or through third-party discount drug programs. These can help reduce the immediate cost for patients, particularly those who are uninsured or have high deductibles. For instance, the manufacturer's co-pay savings program can act as a discount for eligible patients [1]. It is advisable to search for these offers online or inquire at your pharmacy.
When does the patent for Linzess expire?
Information regarding the patent expiry for Linzess can be found on specialized drug patent tracking websites. According to DrugPatentWatch.com, the patent landscape for linaclotide, the active ingredient in Linzess, is complex and involves multiple patents related to composition of matter, methods of use, and manufacturing [2]. Some patents may have already expired or are nearing expiration, while others might offer extended protection. The exact date of patent expiry is crucial for the potential introduction of generic versions of the drug [2].
What are the alternatives to Linzess, and how do their costs compare?
Several other medications are used to treat chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C), the conditions for which Linzess is prescribed. These alternatives include medications like Amitiza (lubiprostone), Trulance (plecanatide), and various osmotic laxatives such as Miralax (polyethylene glycol).
* Amitiza works by increasing fluid secretion in the intestines. Its cost can be comparable to Linzess, with retail prices for a 30-day supply often ranging from $200 to $270 without insurance.
* Trulance is also a guanylate cyclase-C agonist, similar to Linzess. Its retail cost for a 30-day supply is typically in the range of $250 to $300, making it a direct competitor in terms of pricing.
* Osmotic laxatives like Miralax are generally more affordable. A large container of Miralax, which can last for several weeks or months depending on the dosage, might cost between $20 to $40 retail.
The choice of alternative and its associated cost will depend on individual patient response, physician recommendation, and insurance coverage [1].
Sources:
[1] https://www.singlecare.com/prescription/linzess
[2] https://www.drugpatentwatch.com/